Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Sarcoma 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Sarcoma 2Melanoma 2Thyroid Neoplasms 1Spinal Cord Compression 1Neoplasms, Unknown Primary 1Gastrointestinal Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 4trametinib 3pembrolizumab 3Specimen Handling 3ulixertinib 2larotrectinib 2binimetinib 2Surveys and Questionnaires 2Radiosurgery 2Nivolumab 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Cisplatin 2Biopsy 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1tislelizumab 1tipifarnib 1spartalizumab 1sargramostim 1sapanisertib 1romidepsin 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1naporafenib 1lenvatinib 1ipatasertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid Neoplasms × Transurethral Resection of Prostate × Dermatologic × Clear all
NCT02713269 2026-04-17

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
60 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Sarcoma, Spinal Cord Compression, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡